cannepil question and other questions

from the usa here. no one knows anything over there.
so they say once hl pharma gets the import stuff worked out cannepil will immeditaly be distributed right away no delay.
but they also say cannepil is entering phase 2 in europe.
is going into phase 2 in europe so they can get past medical authority in europe and potentially fda in usa?
does australia not require the same clinical trial framework as europe and the usa?
their product will cost 800 to patients for the ?year? or per bottle?
gw pharma uk based company who is introducing a similar product in usa is going to charge 34 thousand usd per year for their child resistant epilepsy cbd product which is expected to be fda approved this june with distribution later in 2018 or 2019.
also is the korean folks saying the shipment they received for the derma product damaged on delivery? is that what the scuttle is about?